Sylvie Dejager
Overview
Explore the profile of Sylvie Dejager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Pen C, Bauduceau B, Ansolabehere X, Troubat A, Bineau S, Ripert M, et al.
Ann Endocrinol (Paris)
. 2021 Jan;
82(2):99-106.
PMID: 33417963
Background: Different countries have their own systems for evaluating new medicines, and they make decisions as to when and how each new medicine is adopted. Purpose: To compare the rate...
2.
Consoli S, Duclos M, Grimaldi A, Penfornis A, Bineau S, Sabin B, et al.
Adv Ther
. 2020 Apr;
37(5):2317-2336.
PMID: 32297283
Introduction: Regular physical activity (PA) is recommended by all type 2 diabetes mellitus (T2DM) management guidelines. The OPADIA study aimed to determine whether using a specific patient questionnaire (Optima-PA©) could...
3.
Barriere P, Avril C, Benmahmoud-Zoubir A, Benard N, Dejager S
Reprod Biomed Soc Online
. 2020 Jan;
9:37-47.
PMID: 31993512
The impact of patient-physician communication and levels of understanding of treatment on patient knowledge and compliance has been studied in patients undergoing their first cycle of infertility treatment. This observational,...
4.
Emery C, Torreton E, Dejager S, Levy-Bachelot L, Bineau S, Detournay B
Diabetes Ther
. 2020 Jan;
11(2):535-548.
PMID: 31953694
Introduction: Diabetes is a growing epidemic that imposes a substantial economic burden on healthcare systems. This study aimed to evaluate the cost of managing type 2 diabetes (T2D) with dipeptidyl...
5.
Michiels Y, Bugnon O, Chicoye A, Dejager S, Moisan C, Allaert F, et al.
Adv Ther
. 2019 May;
36(6):1291-1303.
PMID: 31049873
Introduction: Low-quality communication between patients and care providers and limited patient knowledge of the disease and the therapy are important factors associated with poor glycemic control in patients with type...
6.
Beauchet O, Launay C, Chabot J, Dejager S, Bineau S, Galery K, et al.
Maturitas
. 2019 Feb;
122:1-7.
PMID: 30797525
Background: The 6-item Brief Geriatric Assessment (BGA) provides a priori risk stratification of incident hospital health adverse events, but it has not been used yet to assess the risk of...
7.
Charbonnel B, Simon D, Dallongeville J, Bureau I, Dejager S, Levy-Bachelot L, et al.
Pharmacoecon Open
. 2018 Apr;
2(2):209-219.
PMID: 29623622
Objectives: Our objects was to estimate the direct healthcare costs of type 2 diabetes mellitus (T2DM) in France in 2013. Methods: Data were drawn from a random sample of ≈600,000...
8.
Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N, et al.
Diabetes Care
. 2017 Jan;
40(7):832-838.
PMID: 28039172
Objective: To define the threshold for excess glucose variability (GV), one of the main features of dysglycemia in diabetes. Research Design And Methods: A total of 376 persons with diabetes...
9.
Grimaldi A, Penfornis A, Consoli S, Falissard B, Eymard E, Williams P, et al.
Adv Ther
. 2016 May;
33(6):1033-48.
PMID: 27193870
Background: The OPTIMA© (MSD, Courbevoie, France) questionnaire was developed to promote shared decisions and the set-up of specific micro-objectives in clinical practice by optimizing communication between type 2 diabetes (T2DM)...
10.
Detournay B, Halimi S, Robert J, Deschaseaux C, Dejager S
Vasc Health Risk Manag
. 2015 Aug;
11:417-25.
PMID: 26229480
Aim: We aimed to compare the frequency of severe hypoglycemia leading to hospitalization (HH) and emergency visits (EV) for any cause in patients with type 2 diabetes mellitus exposed to...